)
Niagen Bioscience (NAGE) investor relations material
Niagen Bioscience Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 24, 2026, at 3:00 pm PT in Los Angeles, CA.
Shareholders will vote on director elections, auditor ratification, and executive compensation.
Proxy materials and annual report are available online, with options for electronic or paper delivery.
Voting matters and shareholder proposals
Election of eight directors is up for shareholder vote, with board recommending approval.
Ratification of Crowe LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation as recommended by the Compensation Committee and approved by the board.
Board of directors and corporate governance
Board recommends voting for all eight nominated directors.
Director nominees include Frank Jaksch, Jr., Robert Fried, Steven Rubin, Wendy Yu, Gary Ng, Kristin Patrick, Ann Cohen, and Hamed Shahbazi.
- Net sales up 3% to $31.5M, net income $6.3M, $4.8M segment sale gain, $66.5M cash.NAGE
Q1 20266 May 2026 - Board recommends approval of all proposals, emphasizing governance and performance-linked pay.NAGE
Proxy filing29 Apr 2026 - Double-digit growth, strong margins, and clinical validation drive expansion in NAD+ wellness.NAGE
corporate presentation4 Mar 2026 - Net sales rose 30% and net income more than doubled in 2025, with strong outlook for 2026.NAGE
Q4 20254 Mar 2026 - Patented NAD+ solutions drive profitable growth, clinical trials, and new product innovation.NAGE
17th Annual LD Micro Main Event Conference3 Feb 2026 - Q2 2024 sales up 12% to $22.7M, breakeven net loss, and strong cash position.NAGE
Q2 20242 Feb 2026 - Strong IP, clinical progress, and new verticals position for growth in NAD-related markets.NAGE
Renmark’s Virtual Non-Deal Roadshow Series22 Jan 2026 - Niagen Plus IV launches in major US cities, with rapid expansion and Q3 revenue expected.NAGE
Lytham Partners Fall 2024 Investor Conference20 Jan 2026 - Record Q3 sales, 31% growth, and Niagen+ launch drive strong outlook and profitability.NAGE
Q3 202417 Jan 2026
Next Niagen Bioscience earnings date
Next Niagen Bioscience earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)